Nee A, Lipton JH, Kim DDH. Early prediction of stable MR(4.5) by depth of molecular response at 6 months in patients with chronic myeloid leukemia treated with frontline imatinib. Leuk Lymphoma 2021 Aug 11:1-8. doi: 10.1080/10428194.2021.1961234.
PMID: 34379028